H. Sayer

N. Kröger, A. Zander, R. Brand, 2004, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Hepatic veno-occlusive disease (VOD) with complete occlusion of liver venules after tandem autologous stem cell transplantation – successful treatment with high-dose methylprednisolone and defibrotide

K. Höffken, H. Sayer, K. Schilling, 2002, Journal of Cancer Research and Clinical Oncology.

Deletion of chromosome band 13q14 as detected by fluorescence in situ hybridization is a prognostic factor in patients with multiple myeloma who are receiving allogeneic dose-reduced stem cell transplantation.

H. Einsele, N. Kröger, A. Zander, 2004, Blood.

SIX WEEKS OF CONTINUOUS INTRAVENOUS CYCLOSPORINE AND SHORT‐COURSE METHOTREXATE AS PROPHYLAXIS FOR ACUTE GRAFT‐VERSUS-HOST DISEASE AFTER ALLOGENEIC BONE MARROW TRANSPLANTATION

M. Scheulen, U. Graeven, H. Sayer, 1990, Transplantation.

Acute toxicity and first clinical results of intensive postinduction therapy using a modified busulfan and cyclophosphamide regimen with autologous bone marrow rescue in first remission of acute myeloid leukemia [see comments]

U. Graeven, H. Sayer, D. Beelen, 1989 .

U. Graeven, H. Sayer, D. Beelen, 1989, Blood.

The use of ITS DNA sequence analysis and MALDI‐TOF mass spectrometry in diagnosing an infection with Fusarium proliferatum

M. Ziemer, U. Hipler, M. Erhard, 2008, Experimental dermatology.

Case report: false positive elevated serum‐galactomannan levels after autologous hematopoietic stem cell transplantation caused by oral nutritional supplements

A. Hochhaus, H. Sayer, T. Rachow, 2016, Clinical case reports.

Clinical Management of Posterior Reversible Encephalopathy Syndrome after Allogeneic Hematopoietic Stem Cell Transplantation: A Case Series and Review of the Literature

T. Prell, A. Hochhaus, H. Sayer, 2015, Acta Haematologica.

Constant intravenous pentoxifylline infusions in allogeneic marrow transplant recipients: results of a dose escalation study.

M. Scheulen, H. Sayer, M. Franke, 1993, Bone marrow transplantation.

Outcome of FLT3-ITD-positive acute myeloid leukemia: impact of allogeneic stem cell transplantation and tyrosine kinase inhibitor treatment

S. Scholl, A. Hochhaus, H. Sayer, 2017, Journal of Cancer Research and Clinical Oncology.

Reconstitution and functional analyses of neutrophils and distinct subsets of monocytes after allogeneic stem cell transplantation

S. Scholl, A. Hochhaus, H. Sayer, 2011, Journal of Cancer Research and Clinical Oncology.

Safety and impact of donor‐type red blood cell transfusion before allogeneic peripheral blood progenitor cell transplantation with major ABO mismatch

S. Scholl, K. Höffken, H. Sayer, 2005, Transfusion.

Influence of Growth Suppression of Intestinal Bacteria on the Risk of Acute Graft vs Host Disease After Sibling Marrow Transplantation

U. Graeven, H. Sayer, D. Beelen, 1994 .

Evidence that sustained growth suppression of intestinal anaerobic bacteria reduces the risk of acute graft-versus-host disease after sibling marrow transplantation.

U. Graeven, H. Sayer, D. Beelen, 1992, Blood.

First Report of a Prospective Randomised Controlled Trial of Recombinant Human Erythropoietin after Allogeneic Blood Stem Cell Transplantation.

S. Scholl, H. Sayer, K. Hoeffken, 2004 .

Using a Modified Busulfan and Cyclophosphamide Regimen With Autologous Bone Marrow Rescue in First Remission of Acute Myeloid Leukemia

U. Graeven, H. Sayer, D. Beelen, 2005 .

Initial treatment of acute graft-versus-host disease with a murine monoclonal antibody directed to the human α/β T cell receptor

U. Graeven, H. Sayer, H. Grosse-wilde, 2005, Cancer Immunology, Immunotherapy.

N. Schmitz, N. Kröger, A. Zander, 2002, Blood.

Allogeneic hematopoietic stem cell transplantation improves long-term outcome for relapsed AML patients across all ages: results from two East German Study Group Hematology and Oncology (OSHO) trials

D. Niederwieser, S. Scholl, C. Junghanss, 2021, Annals of Hematology.

Automated detection of residual cells after sex-mismatched stem-cell transplantation – evidence for presence of disease-marker negative residual cells

T. Kroll, T. Johannes, M. Hoffmann, 2009, Molecular Cytogenetics.

Clinical results and the Essen concept of TBI.

H. Sack, M. Molls, M. Bamberg, 1990, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Premenopausal Breast Cancer

K. Kliche, K. Höffken, H. Sayer, 2012, Drugs.

Long-term follow-up of the AML97 study for patients aged 60 years and above with acute myeloid leukaemia: a study of the East German Haematology and Oncology Study Group (OSHO)

D. Niederwieser, S. Scholl, C. Junghanss, 2015, Journal of Cancer Research and Clinical Oncology.

Combined standard graft-versus-host disease (GvHD) prophylaxis with mycophenolate mofetil (MMF) in allogeneic peripheral blood stem cell transplantation from unrelated donors

S. Scholl, K. Höffken, H. Sayer, 2004, Bone Marrow Transplantation.

Comparison between antithymocyte globulin and alemtuzumab and the possible impact of KIR‐ligand mismatch after dose‐reduced conditioning and unrelated stem cell transplantation in patients with multiple myeloma

N. Kröger, S. Iacobelli, A. Zander, 2005, British journal of haematology.

Distinct reconstitution of neutrophil functions after allogeneic peripheral blood stem cell transplantation

S. Scholl, K. Höffken, H. Sayer, 2007, Journal of Cancer Research and Clinical Oncology.

Different treatment strategies versus a common standard arm (CSA) in patients with newly diagnosed AML over the age of 60 years: a randomized German inter-group study

W. Hiddemann, B. Dörken, A. Krämer, 2023, Annals of Hematology.

Response-Adapted Sequential Treatment with Azacitidine and Intensive Chemotherapy in Patients > 60 Years Old with Newly Diagnosed AML: Results of the RAS-Azic Trial of the East German Study Group (OSHO)

D. Niederwieser, M. Cross, H. Al-Ali, 2017 .

Comparison of Treatment Strategies in Patients over 60 Years with AML: Final Analysis of a Prospective Randomized German AML Intergroup Study

W. Hiddemann, A. Krämer, D. Niederwieser, 2016 .

Risk factors for outcome in refractory acute myeloid leukemia patients treated with a combination of fludarabine, cytarabine, and amsacrine followed by a reduced-intensity conditioning and allogeneic stem cell transplantation

G. Behre, D. Niederwieser, H. Al-Ali, 2015, Journal of Cancer Research and Clinical Oncology.

Explaining survival differences between two consecutive studies with allogeneic stem cell transplantation in patients with chronic myeloid leukemia

H. Heimpel, J. Hasford, A. Ganser, 2014, Journal of Cancer Research and Clinical Oncology.

Increased risk of infection in marrow transplant patients receiving methylprednisolone for graft-versus-host disease prevention.

M. Pepe, R. Storb, G. Longton, 1994, Blood.

Treatment of acute graft-versus-host disease after HLA-partially matched marrow transplantation with a monoclonal antibody (BMA031) against the T cell receptor. First results of a phase-I/II trial.

C. Schmidt, U. Graeven, H. Sayer, 1988, Onkologie.

Risk-adapted, treosulfan-based therapy with auto- and allo-SCT for relapsed/refractory aggressive NHL: a prospective phase-II trial

A. Ganser, G. Behre, A. Hinke, 2014, Bone Marrow Transplantation.

Influence of treatment modality, patient/donor characteristics, and disease stage on the risk of relapse after allogeneic marrow transplantation for acute leukemia.

U. Graeven, H. Sayer, D. Beelen, 1990, Haematology and blood transfusion.

Allogeneic and autologous bone marrow transplantation in acute leukemia: the Essen Experience.

R. Becher, U. Graeven, H. Sayer, 1990, Haematology and blood transfusion.

Full or intensity‐reduced high‐dose melphalan and single or double autologous stem cell transplant with or without bortezomib consolidation in patients with newly diagnosed multiple myeloma

H. Einsele, F. Bassermann, M. Vogel, 2021, European journal of haematology.

Treatment with granulocyte colony-stimulating factor for mobilization of bone marrow cells in patients with acute myocardial infarction.

H. Figulla, K. Pachmann, T. Opfermann, 2005, American heart journal.

Irinotecan in patients with relapsed or cisplatin-refractory germ cell cancer: a phase II study of the German Testicular Cancer Study Group

C. Bokemeyer, L. Kanz, F. Mayer, 2002, British Journal of Cancer.

Activity of oxaliplatin in patients with relapsed or cisplatin-refractory germ cell cancer: a study of the German Testicular Cancer Study Group.

C. Bokemeyer, L. Kanz, M. Kuczyk, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Early versus late administration of pegfilgrastim after high-dose chemotherapy and autologous hematopoietic stem cell transplantation

A. Hinke, M. Freund, H. Sayer, 2012, Journal of Cancer Research and Clinical Oncology.

Results from two phase III studies of bortezomib (BTZ) consolidation vs observation (OBS) post-transplant in patients (pts) with newly diagnosed multiple myeloma (NDMM).

H. Einsele, F. Bassermann, M. Vogel, 2015 .

Comparison between Anti-Thymocyte Globulin and Alemtuzumab and the Possible Impact of KIR-Ligand Mismatch in Melphalan/Fludarabine Dose-Reduced Conditioning Followed by HLA-Matched and Mismatched Unrelated Stem Cell Transplantation in Patients with Multiple Myeloma.

S. Iacobelli, A. Nagler, K. Peggs, 2004 .

Allogeneic blood stem cell transplantation in advanced chronic myeloid leukemia--high response rate associated with increased chronic graft-versus-host disease.

S. Scholl, K. Höffken, H. Sayer, 2003, Haematologica.

Chronic persistent parvovirus B19 bone marrow infection resulting in transfusion-dependent pure red cell aplasia in multiple myeloma after allogeneic haematopoietic stem cell transplantation and severe graft versus host disease

I. Petersen, A. Hochhaus, H. Sayer, 2017, Hematology.

Preferred co-localization of chromosome 8 and 21 in myeloid bone marrow cells detected by three dimensional molecular cytogenetics.

A. Lier, K. Mrasek, T. Liehr, 2009, International journal of molecular medicine.

Acute Abdomen by Varicella Zoster Virus Induced Gastritis after Autologous Peripheral Blood Stem Cell Transplantation in a Patient with Non-Hodgkin’s Lymphoma

S. Scholl, K. Höffken, M. Hocke, 2006, Acta Haematologica.

Biomarker candidates for the detection of an infectious etiology of febrile neutropenia

C. Engel, F. Brunkhorst, S. Hagel, 2016, Infection.

Genitourinary tumors, non-prostate

S. J. Park, I. Tannock, S. Groshen, 2012 .

The risk of infections in multiple myeloma before and after the advent of novel agents: a 12-year survey

A. Scherag, S. Scholl, A. Hochhaus, 2019, Annals of Hematology.

Melphalan 200 mg/m2 does not increase toxicity and improves survival in comparison to reduced doses of melphalan in multiple myeloma patients

P. Rucci, S. Scholl, A. Hochhaus, 2020, Bone Marrow Transplantation.

Response-adapted consolidation with bortezomib after ASCT improves progression-free survival in newly diagnosed multiple myeloma

H. Einsele, F. Bassermann, M. Vogel, 2017, Leukemia.

Exanthema in Legionnaires’ disease mimicking a severe cutaneous drug reaction

M. Ziemer, H. Sayer, R. Voigt, 2009, Clinical and experimental dermatology.

Improvement of leukemia-free survival (LFS) and reduction of relapse incidence by allogeneic stem cell transplantation (SCT) in elderly patients (pts) with AML irrespective of the FLT3-ITD and npm status except npm+/flt3(ITD)-.

D. Niederwieser, C. Junghanss, T. Fischer, 2010 .

Very Late Appearance of Acute Graft‐versus‐Host Disease after Tapering Immunosuppression

U. Wollina, H. Sayer, T. Graefe, 2001, The Journal of dermatology.

N. Schmitz, N. Kröger, A. Zander, 2002, Blood.

[Respiratory failure and pulmonary fibrosis as a late side-effect after chemotherapy-induced by oxygen administration].

H. Sayer, M. Brauer, L. Hüter, 2005, Pneumologie.

Clinical implications of molecular genetic aberrations in acute myeloid leukemia

S. Scholl, K. Höffken, H. Sayer, 2009, Journal of Cancer Research and Clinical Oncology.

Full Dose or Reduced Dose Melphalan (MEL) for Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma (MM): A Single Center Analysis on 187 Consecutive Patients

S. Scholl, A. Hochhaus, H. Sayer, 2018, Blood.

Impairment in functional status and survival in patients with acute myeloid leukaemia

B. Röhrig, K. Höffken, H. Sayer, 2006, Journal of Cancer Research and Clinical Oncology.

Nonmyeloablative stem cell transplantation in adults with high-risk ALL may be effective in early but not in advanced disease

A. Ho, U. Hegenbart, G. Ehninger, 2002, Leukemia.

Allogeneic haematopoietic cell transplantation for chronic myelogenous leukaemia in the era of imatinib: a retrospective multicentre study

N. Kröger, G. Ehninger, H. Wandt, 2006, European journal of haematology.

Paraneoplastic inflammation in myelodysplastic syndrome or bone marrow failure: case series with focus on 5‐azacytidine and literature review

S. Scholl, A. Hochhaus, H. Sayer, 2014, European journal of haematology.

Explaining survival differences between two consecutive studies with allogeneic stem cell transplantation in patients with chronic myeloid leukemia

H. Heimpel, J. Hasford, A. Ganser, 2014, Journal of Cancer Research and Clinical Oncology.

Pneumocystis carinii pneumonia as a complication of bendamustine monotherapy in a patient with advanced progressive breast cancer

K. Höffken, H. Sayer, C. Schneider, 2003, Journal of Cancer Research and Clinical Oncology.